DE RUYCK PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DE RUYCK PHARMA
Largest movements
- Tangible fixed assets -€48,827
down €48,827 (-4.2%), from €1.2m to €1.1m
of which Land and buildings: -€46,824
- Intangible fixed assets -€24,000
down €24,000 (-50.0%), from €48,000 to €24,000
- Stocks and contracts -€22,383
down €22,383 (-13.0%), from €172,823 to €150,440
- Receivables within one year -€18,716
down €18,716 (-15.3%), from €122,096 to €103,381
of which Trade receivables: -€15,770
- Cash -€17,188
down €17,188 (-20.8%), from €82,605 to €65,417
mainly Debts after one year (-€78,939) and Contributions, distributions and other (-€41,511)
- Debts after one year -€78,939
down €78,939 (-7.8%), from €1.0m to €927,262
- Trade debts -€36,307
down €36,307 (-21.1%), from €172,087 to €135,781
- Current portion of long-term debt -€32,081
down €32,081 (-28.9%), from €111,020 to €78,939
- Gross operating margin +€21,023
up €21,023 (+11.8%), from €178,233 to €199,257
- Depreciation +€14,636
up €14,636 (+17.1%), from €85,486 to €100,122
- Staff costs +€5,497
up €5,497 (+112%), from €4,911 to €10,408
- Financial income -€4,682
down €4,682 (-63.7%), from €7,351 to €2,669
- Financial charges -€2,002
down €2,002 (-10.6%), from €18,862 to €16,860
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,600,849 | €1,471,263 | -€129,586 | -8.1% |
| Fixed assets | 21/28 | €1,215,169 | €1,142,342 | -€72,827 | -6.0% |
| Intangible fixed assets | 21 | €48,000 | €24,000 | -€24,000 | -50.0% |
| Tangible fixed assets | 22/27 | €1,164,669 | €1,115,842 | -€48,827 | -4.2% |
| Land and buildings | 22 | €1,094,641 | €1,047,817 | -€46,824 | -4.3% |
| Plant, machinery and equipment | 23 | €45,870 | €29,534 | -€16,336 | -35.6% |
| Furniture and vehicles | 24 | €24,158 | €38,491 | +€14,333 | +59.3% |
| Financial fixed assets | 28 | €2,500 | €2,500 | = | 0.0% |
| Current assets | 29/58 | €385,680 | €328,921 | -€56,759 | -14.7% |
| Stocks and contracts in progress | 3 | €172,823 | €150,440 | -€22,383 | -13.0% |
| Stocks | 30/36 | €172,823 | €150,440 | -€22,383 | -13.0% |
| Amounts receivable within one year | 40/41 | €122,096 | €103,381 | -€18,716 | -15.3% |
| Trade receivables | 40 | €81,743 | €65,972 | -€15,770 | -19.3% |
| Other amounts receivable | 41 | €40,354 | €37,408 | -€2,946 | -7.3% |
| Cash at bank and in hand | 54/58 | €82,605 | €65,417 | -€17,188 | -20.8% |
| Deferred charges and accrued income | 490/1 | €8,156 | €9,684 | +€1,528 | +18.7% |
| Total equity and liabilities | 10/49 | €1,600,849 | €1,471,263 | -€129,586 | -8.1% |
| Equity | 10/15 | €300,199 | €306,908 | +€6,708 | +2.2% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €280,962 | €287,671 | +€6,708 | +2.4% |
| Non-distributable reserves | 130/1 | €224,106 | €0 | -€224,106 | -100% |
| Other | 1319 | €224,106 | €0 | -€224,106 | -100% |
| Tax-exempt reserves | 132 | €25,636 | €25,636 | = | 0.0% |
| Distributable reserves | 133 | €31,220 | €262,035 | +€230,815 | +739% |
| Profit (loss) carried forward | 14 | €637 | €637 | = | 0.0% |
| Amounts payable | 17/49 | €1,300,650 | €1,164,355 | -€136,294 | -10.5% |
| Amounts payable after more than one year | 17 | €1,006,201 | €927,262 | -€78,939 | -7.8% |
| Financial debts | 170/4 | €1,006,201 | €927,262 | -€78,939 | -7.8% |
| Amounts payable within one year | 42/48 | €293,851 | €236,605 | -€57,246 | -19.5% |
| Current portion of amounts payable after more than one year | 42 | €111,020 | €78,939 | -€32,081 | -28.9% |
| Financial debts | 43 | - | €12,537 | +€12,537 | |
| Credit institutions | 430/8 | - | €12,537 | +€12,537 | |
| Trade debts | 44 | €172,087 | €135,781 | -€36,307 | -21.1% |
| Suppliers | 440/4 | €172,087 | €135,781 | -€36,307 | -21.1% |
| Taxes, remuneration and social security | 45 | €10,744 | €7,349 | -€3,396 | -31.6% |
| Taxes | 450/3 | €7,600 | €6,564 | -€1,036 | -13.6% |
| Remuneration and social security | 454/9 | €3,144 | €784 | -€2,360 | -75.1% |
| Other amounts payable | 47/48 | - | €2,000 | +€2,000 | |
| Accrued charges and deferred income | 492/3 | €598 | €488 | -€110 | -18.3% |
| Remuneration, social security and pensions | 62 | €4,911 | €10,408 | +€5,497 | +112% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €85,486 | €100,122 | +€14,636 | +17.1% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€701 | €0 | +€701 | |
| Other operating charges | 640/8 | €5,137 | €5,980 | +€842 | +16.4% |
| Non-recurring operating charges | 66A | €976 | - | -€976 | |
| Gross operating margin | 9900 | €178,233 | €199,257 | +€21,023 | +11.8% |
| Operating profit (loss) | 9901 | €82,423 | €82,746 | +€323 | +0.4% |
| Financial income | 75/76B | €7,351 | €2,669 | -€4,682 | -63.7% |
| Recurring financial income | 75 | €7,351 | €2,669 | -€4,682 | -63.7% |
| Financial charges | 65/66B | €18,862 | €16,860 | -€2,002 | -10.6% |
| Recurring financial charges | 65 | €18,862 | €16,860 | -€2,002 | -10.6% |
| Profit (loss) for the period before taxes | 9903 | €70,911 | €68,555 | -€2,356 | -3.3% |
| Income taxes | 67/77 | €20,856 | €20,336 | -€520 | -2.5% |
| Profit (loss) for the period | 9904 | €50,055 | €48,219 | -€1,836 | -3.7% |
| Profit (loss) for the period to be appropriated | 9905 | €50,055 | €48,219 | -€1,836 | -3.7% |
Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.